ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1174

Analysis of In-Hospital Mortality Risk Factors and Establishment of a Nomogram Prediction Model for Patients with Stage 5 CKD in the Intensive Care Unit (ICU)

Session Information

Category: CKD (Non-Dialysis)

  • 2302 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Author

  • Liu, Fanna, The First Affiliated Hospital of Jinan University, Nephrology, Guangzhou, China
Background

Patients with stage 5 chronic kidney disease (CKD5) have a high risk of mortality. ICU patients have lots of abnormal results. Defining the risk factors for in-hospital mortality in ICU CKD5 patients will help doctors pay more attention to the most important factors and intervene in a timely manner. In this study, we analyzed the risk factors related to in-hospital mortality and drew the nomogram to predict in-hospital mortality in CKD5 non-dialysis (CKD 5ND) patients.

Methods

According to the diagnosis code, 495 CKD 5ND patients were selected from the MIMIC-IV database. The differences between the survival group and the death group were analyzed by two independent samples t-test, rank-sum test, or chi-square test. The nomograms to predict the risk of in-hospital mortality in CKD 5ND patients were established respectively. In order to evaluate the nomogram, ROC curve, calibration curve, and DCA curve were used. Boostrap-resampling was used for internal verification. eICU patients were used for external verification. And the predictive performance of the nomogram was compared with commonly scores.

Results

There were 1439 CKD5 patients in the MIMIC-IV database, including 495 non-dialysis patients. There were 425 CKD5 ND patients in the survival group and 70 patients in the death group. Age, SBP, WBC, RDW, and BUN/Scr were the correlation factors for in-hospital mortality in CKD5 ND patients. Internal and external validation showed that the CKD5 ND patients nomogram prediction model had good calibration, clinical benefit, and discrimination (training set AUC=0.832, validation set AUC=0.770). The predictive ability of nomogram was better than the three commonly used scores.

Conclusion

The nomogram prediction model predicting in-hospital mortality of CKD5 ND patients has good discrimination, calibration, and clinical value, which are established by Age, SBP, WBC, RDW, and BUN/Scr.